Stay updated on Pembrolizumab Combo in Metastatic NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Metastatic NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Metastatic NSCLC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The study page now returns a 403 Forbidden error, blocking access to the study record and its documents. The visible layout shows a 403 message with header and footer, replacing the expected study content.
    Difference
    18%
    Check dated 2026-09-19T22:21:07.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The page now includes related topics metadata (Lung cancer and MedlinePlus Genetics) to help users access background information from linked resources.
    Difference
    0.1%
    Check dated 2026-09-12T19:19:34.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The NIH grant/contract note was added to the study identifiers, and the page revision was updated to v3.6.6 (replacing v3.6.5).
    Difference
    0.1%
    Check dated 2026-08-29T18:59:27.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.4 to v3.6.5, signaling a minor update to the study record. This does not imply a substantive change to the study details.
    Difference
    0.0%
    Check dated 2026-08-08T11:27:22.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Lung cancer and the related topics section, including MedlinePlus Genetics, were removed from the page content. This changes the list of linked topics shown but does not alter the study's design, endpoints, or enrollment information.
    Difference
    0.1%
    Check dated 2026-08-01T11:08:14.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    The page now lists Lung cancer and related topics, and adds a MedlinePlus Genetics reference. The revision tag was updated from v3.6.3 to v3.6.4.
    Difference
    0.1%
    Check dated 2026-07-25T06:39:49.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Metastatic NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Metastatic NSCLC Clinical Trial page.